New Results
Determination of Slow-binding HDAC Inhibitor Potency and Subclass Selectivity
View ORCID ProfileCarlos Moreno-Yruela, View ORCID ProfileChristian A. Olsen
doi: https://doi.org/10.1101/2021.12.18.473277
Carlos Moreno-Yruela
Center for Biopharmaceuticals & Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen DK-2100, Copenhagen, Denmark
Christian A. Olsen
Center for Biopharmaceuticals & Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen DK-2100, Copenhagen, Denmark
Posted March 02, 2022.
Determination of Slow-binding HDAC Inhibitor Potency and Subclass Selectivity
Carlos Moreno-Yruela, Christian A. Olsen
bioRxiv 2021.12.18.473277; doi: https://doi.org/10.1101/2021.12.18.473277
Subject Area
Subject Areas
- Biochemistry (12782)
- Bioengineering (9670)
- Bioinformatics (31243)
- Biophysics (16089)
- Cancer Biology (13174)
- Cell Biology (18846)
- Clinical Trials (138)
- Developmental Biology (10201)
- Ecology (15183)
- Epidemiology (2067)
- Evolutionary Biology (19392)
- Genetics (12879)
- Genomics (17772)
- Immunology (12898)
- Microbiology (30188)
- Molecular Biology (12605)
- Neuroscience (65883)
- Paleontology (486)
- Pathology (2041)
- Pharmacology and Toxicology (3516)
- Physiology (5446)
- Plant Biology (11282)
- Synthetic Biology (3122)
- Systems Biology (7763)
- Zoology (1756)